Our strength is in our breadth
Northern New South Wales is quickly emerging as a nationwide leader in the production of - and research into - medicinal cannabis.
A New England grower has been given the state's first license to mass produce cannabis oil - a move which should substantially lower prices.
NBN News was given an exclusive tour by the company.
As part of its commitment to environmental responsibility, Murray Meds has constructed a solar array to harness the abundant sunshine they receive at their site in Northern Victoria. This will offset an estimated 500 tonnes of CO2 emissions, which is the equivalent of taking almost 6 cars permanently off the road.
Click picture above for full story - commentary and extracts from the article below:
Last week, the TGA released an interim decision to amend the Poisons Standard to allow cannabidiol to be sold over the counter at a restricted dose to adults.
Although this, at first, may have seemed like good news, new research published in the International Journal of Drug Policy suggests the TGA's plan to allow chemists to sell a month's worth of cannabidiol at a maximum dose of 60mg per day is unlikely to benefit patients.
The paper's co-author, Professor Iain McGregor, academic director of Sydney University's Lambert Initiative for Cannabinoid Therapeutics, said much higher doses were needed to give relief to patients with chronic pain, insomnia, anxiety and epilepsy.
The public is invited to comment until October 13. A final decision is due in late November, with implementation in February. There are considerable issues with this proposed listing as it stands. The experts have commented. Now it's your turn to make your voice heard.